11:52 IST
BSE
Business Update
Haleos Labs Business Update
USFDA inspected the material subsidiary Mahi Drugs' API facility in Parawada. The inspection concluded with zero Form 483 observations.
Haleos Labs Ltd
- Share price
- ₹1,501.80
- Market cap
- ₹454.0 Cr
- Revenue (annual)
- ₹333.8 Cr
- Net profit (annual)
- ₹17.31 Cr
- P/E (TTM)
- 28.7×Sector 50.4×
- Promoter holding
- 72.11%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
6 announcements
18:58 IST
BSE
Other Announcement
Haleos Labs Other Announcement
Haleos Labs Ltd notified shareholders of the Annual Report and AGM notice weblink, while requesting updates to their KYC and email addresses.
16:34 IST
BSE
Annual Report
Haleos Labs Annual Report
Haleos Labs Ltd has submitted its Annual Report for the financial year 2025-26, along with the Notice for its 20th Annual General Meeting.
18:26 IST
BSE
Dividend
Haleos Labs Dividend
Haleos Labs Limited recommended a final dividend of ₹15 per equity share for FY 2025-26. The record date is fixed for September 23, 2026.
13:48 IST
NSE
Financial Results
Haleos Labs Q1 FY27 Results: Net Profit ₹1.8 Cr, Down 59.1% YoY
Haleos Labs Ltd reported revenue from operations of ₹72.9 Cr (-11.6% YoY) and net profit of ₹1.8 Cr (-59.1% YoY) for Q1 FY27.
- Key figure
- Net profit ₹1.8 Cr · -59.1% YoY
15:50 IST
BSE
Financial Results
Haleos Labs Q4 FY26 Results: Net Profit ₹0.3 Cr, Down 91.4% YoY
Haleos Labs Ltd reported revenue from operations of ₹75.1 Cr (-15.7% YoY) and net profit of ₹0.3 Cr (-91.4% YoY) for Q4 FY26.
- Key figure
- Net profit ₹0.3 Cr · -91.4% YoY